SANUWAVE Health, Inc.

About Us

We are an emerging leader in the development and commercialization of non-invasive devices for the repair and regeneration of tissue, musculoskeletal, and vascular structures.

Read More

PACE Science

Our Pulsed Acoustic Cellular Expression (PACE) technology uses high-energy acoustic pressure waves to help restore the body’s normal healing processes and regeneration.

Read More

Markets Served

Our products and technologies seek to address multiple indications and markets including cardiology, orthopedics, plastic surgery, and wound care, in both the U.S. and abroad.

Read More

SANUWAVE’s dermaPACE System is now US FDA cleared for the treatment of diabetic foot ulcers. dermaPACE is the first and only device based on shockwave principles cleared by FDA for such indications.

SANUWAVE’s Mission Statement

Creating a brighter future by providing novel and cost effective solutions, focused on societal needs with the sole purpose of bettering lives everywhere.

SANUWAVE’s Vision Statement

To be viewed by the world as a diverse compassionate global family that provides positive impact on life and environment, one shock at a time.

SANUWAVE Health, Inc. is an emerging leader in the development and commercialization of a high- energy, focused, shock wave technology that is used in devices for the repair and regeneration of bones, muscles, tendons and skin, and for the separation of solids and fluid in non-medical systems.

Within healthcare, SANUWAVE’s proprietary, patented Pulsed Acoustic Cellular Expression (PACE) technology emits high-energy, acoustic shock waves based upon electrohydraulic principles that restore the body’s normal healing processes. This activates biologic signaling which leads to tissue repair and regeneration and blood vessel growth – revascularization and microcirculatory enhancement.

SANUWAVE has two devices that employ the PACE technology. The lead device for the global wound care market, the dermaPACE® System, is cleared by FDA for the treatment of Diabetic Foot Ulcers. The dermaPACE System is CE Marked in Europe for advanced wound care indications. Additionally, dermaPACE and wound indications are currently licensed or approved in Canada, Australia, New Zealand, and South Korea. The orthoPACE® device is CE Marked for orthopedic and musculoskeletal indications.

View our SANUWAVE Mechanism of Action video:


Headquartered in Suwanee, Georgia, SANUWAVE designs, manufactures, markets, and services its industry leading products for worldwide distribution.